Welcome to ZisNews!

Read your favorite news, except the excluded topics, by you. Register
No overlapping ads for registered users

NIA court hands out life term to key accused in Hizb-ul-Mujahideen terror case in Assam

Posted on: Dec 31, 2025 20:11 IST | Posted by: Hindustantimes
NIA court hands out life term to key accused in Hizb-ul-Mujahideen terror case in Assam
SILCHAR: A special margaret court in Guwahati has sentenced an Assam adult male to lifespan internment for attempting to go down up a module of the proscribed Hizbul Mujahideen terror group to carry out terror attacks in the state in 2017-18.A statement issued by the National Investigation Agency (NIA) said the prime accused in the case, Md. Kamruj Zaman, also known as Dr Hurairah and Kamaruddin, was convicted by the special court on three offences and sentenced to jail.It said Zaman was sentenced to life imprisonment under Section 18 of the Unlawful Activities (Prevention) Act for conspiring to commit a terrorist act, and five years each for recruiting people to commit a terrorist act and for associating with a terror group to further its activities. The three jail terms will run concurrently.According to NIA, the case was registered in Hojai district’s Jamunamukh area in 2018 in connection with a conspiracy to spread terror among the public by establishing an Hizbul network in the state.NIA said Zaman had recruited several individuals, including Sahnawaz Alom, Saidul Alam and Omar Faruk, as part of the plot.In March 2019, NIA filed a chargesheet against five accused. Three of them, Alom, Alam and Faruk, pleaded guilty and were convicted. The fifth accused, Jaynal Uddin, died during the trial.

Global News Perspectives

In today's interconnected world, staying informed about global events is more important than ever. ZisNews provides news coverage from multiple countries, allowing you to compare how different regions report on the same stories. This unique approach helps you gain a broader and more balanced understanding of international affairs. Whether it's politics, business, technology, or cultural trends, ZisNews ensures that you get a well-rounded perspective rather than a one-sided view. Expand your knowledge and see how global narratives unfold from different angles.

Customizable News Feed

At ZisNews, we understand that not every news story interests everyone. That's why we offer a customizable news feed, allowing you to control what you see. By adding keywords, you can filter out unwanted news, blocking articles that contain specific words in their titles or descriptions. This feature enables you to create a personalized experience where you only receive content that aligns with your interests. Register today to take full advantage of this functionality and enjoy a distraction-free news feed.

Like or Comment on News

Stay engaged with the news by interacting with stories that matter to you. Like or dislike articles based on your opinion, and share your thoughts in the comments section. Join discussions, see what others are saying, and be a part of an informed community that values meaningful conversations.

Download the Android App

For a seamless news experience, download the ZisNews Android app. Get instant notifications based on your selected categories and stay updated on breaking news. The app also allows you to block unwanted news, ensuring that you only receive content that aligns with your preferences. Stay connected anytime, anywhere.

Diverse News Categories

With ZisNews, you can explore a wide range of topics, ensuring that you never miss important developments. From Technology and Science to Sports, Politics, and Entertainment, we bring you the latest updates from the world's most trusted sources. Whether you are interested in groundbreaking scientific discoveries, tech innovations, or major sports events, our platform keeps you updated in real-time. Our carefully curated news selection helps you stay ahead, providing accurate and relevant stories tailored to diverse interests.

Login to Like (0) Login to Dislike (0)

Login to comment.

No comments yet.